Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $3.70, but opened at $3.92. Raia Drogasil shares last traded at $3.92, with a volume of 347 shares trading hands.
Raia Drogasil Price Performance
The business has a fifty day moving average of $3.62 and a 200 day moving average of $4.05.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. The business had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Equities analysts anticipate that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Articles
- Five stocks we like better than Raia Drogasil
- With the RSI at a Record Low, Is It Time to Go Bargain Hunting on Burlington?
- Could IonQ Become More Than a Quantum Computing Company?
- Why China’s Memory Chip Breakthrough Won’t Crash the Market
- Enova’s Earnings Surge Meets a Valuation Test
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
